CTNM- Contineum Therapeutics, Inc.

Name: Contineum Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Contineum Therapeutics, Inc. (CTNM) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. CTNM is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Stengone Carmine N.	445.0K	$6.51M	-
Other	Healy John Stephen	206.4K	$3.02M	-
CFO	Slover Peter T	192.0K	$2.81M	-
Other	Lorrain Daniel S.	143.8K	$2.10M	-4,170
Dir	Schimmelpennink Evert B.	14.8K	$215.8K	-

Activity

Buys and sells only

Transactions

9 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 1, 2026	Lorrain Daniel S.64	Chief Scientific Officer	Sell	4,170	$13.12	$54,694.20	-1.4%	-	-
Mar 2, 2026	Watkins Tim	CMO &Head Of Development	Sale+OE	3,611	$15.02	$54,220.25	-100%	-	-
Feb 3, 2026	Lorrain Daniel S.64	Chief Scientific Officer	Sell	4,170	$14.94	$62,305.47	-1.3%	-13.2%	-
Jan 28, 2026	Watkins Tim	CMO &Head Of Development	Sale+OE	3,611	$14.18	$51,188.25	-81.7%	-13.1%	-
Jan 5, 2026	Lorrain Daniel S.64	Chief Scientific Officer	Sell	4,170	$10.44	$43,543.16	-1.3%	+34.4%	-
Dec 29, 2025	Watkins Tim	CMO &Head Of Development	Sale+OE	3,611	$12.06	$43,558.41	-100%	+3.2%	-
Dec 23, 2025	Lorrain Daniel S.64	Chief Scientific Officer	Sell	4,170	$12.23	$51,009.11	-2.5%	+0.9%	-
Nov 25, 2024	Lorrain Daniel S.64	Chief Scientific Officer	Sell	1,010	$16.02	$16,177.37	-0.6%	-50.6%	-30.3%
Nov 18, 2024	Lorrain Daniel S.64	Chief Scientific Officer	Sell	6,190	$16.38	$101,420.77	-1.8%	-53.5%	-27.3%

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC